Series B · Edtech · Berlin, Germany · Founded 2012 · 600–700 employees
AMBOSS is a leading medical education and clinical decision-making platform founded in 2012 by physicians. The platform revolutionized medical education by combining cutting-edge technology with evidence-based medical knowledge, serving over 1 million users in 180+ countries. AMBOSS is now used by over 90% of medical students in Germany and the majority of US medical students, with every second inpatient treatment in Germany supported by a physician using AMBOSS. The company recently raised €240 million in 2025 to expand internationally and into nursing education through acquisitions like Novaheal.